Vigovi vs. Tipovidone: Which weight loss injection is better for you?

In recent years, GLP-1 receptor agonists have become a popular choice for weight loss management , with vegravi (semaglutide) and telpotide being two of the most watched weight-loss injections . Both drugs have been approved by the U.S. Food and Drug Administration ( FDA ) and are effective in reducing weight and improving metabolic health.

Although they all belong to the GLP-1 class of drugs, they still differ significantly in their mechanisms of action, weight loss effects, side effects, and suitable populations . So, which one is more suitable for you? This article will conduct an in-depth comparison from multiple perspectives to help you find the weight loss plan that best suits your needs.

 

1. Comparison of mechanisms of action

drug	Mechanism of action	Main features
Vigovi (Smegglutinin)	GLP-1 receptor agonists	It primarily reduces appetite, slows gastric emptying, and lowers calorie intake.
Telpoeptide	GLP-1 + GIP dual agonist	The additional GIP effect promotes fat breakdown and improves insulin sensitivity.

Key differences :

•       Vigorvi primarily helps with weight loss by reducing appetite and slowing gastric emptying , with less direct effect on fat metabolism.

•       In addition to reducing appetite, telpoeptide can also promote fat breakdown and improve insulin sensitivity through GIP action, thus resulting in a stronger weight loss effect.

 

2. Weight loss effect comparison: Which is more effective?

drug	Clinical research data	Average weight loss
Vigovi ( STEP-1 study)	After 68 weeks, the highest dose group (2.4 mg )	Weight loss of 16.9%
Study of sulfonamide ( SURMOUNT-1 )	After 72 weeks, the highest dose of 15 mg group	Weight loss of 22.5%

Key data analysis :

•       Thiprotide resulted in 5.6% greater weight loss than Vigovite , making it the most effective of all FDA -approved weight loss drugs.

•       In the SURMOUNT-1 study, more than 57% of telpoide users experienced a weight loss of more than 20% , compared to 36% of vigovi users.

•       Telbeptide not only reduces calorie intake but also accelerates fat burning, making weight management more efficient.

 

3. Side effects comparison: Which is easier to tolerate?

side effect	Vigovi (Smegglutinin)	Telpoeptide
nausea	high	Low
Vomit	high	Low
Diarrhea / Constipation	Possible	Possible
Hypoglycemia (in non-diabetic individuals)	Low	Low
Weight rebound after stopping medication	It may be faster	Relatively slow

in conclusion :

•       Due to its GIP effect, telpolide has milder gastrointestinal side effects than vegravicil and is better tolerated by users .

•       Vigavi results in a faster weight gain after discontinuation, while telpotetide provides more stable long-term maintenance effects .

 

4. Comparison of suitable populations: Who is more suitable for which drug?

Target audience	Vigovi (Smegglutinin)	Telpoeptide
Hoping for gentle weight loss ( 10-15% body weight reduction)	✅ Suitable	❌ Telborpeptide may cause excessively rapid weight loss.
Desiring maximum weight loss ( >20% weight reduction)	❌ Possibly insufficient	✅ More suitable
Gastrointestinal sensitivity, prone to nausea and vomiting	❌ It may be difficult to tolerate.	✅ Mild side effects
I previously used Vigavi, but the results were unsatisfactory.	❌ It may still be impossible to achieve the goal.	✅ stronger weight loss effect
People with prediabetes and metabolic syndrome	✅ Suitable	✅ More suitable ( GIP can improve insulin sensitivity)
Unwilling to adjust eating habits	✅ Suitable	✅ Suitable

in conclusion :

•       If your goal is moderate weight loss ( 10-15% weight loss), Vigavi is a good option .

•       If the goal is significant weight loss ( >20% weight loss), or if Vigevich is ineffective, Telpoeptide is a better option .

•       People with sensitive gastrointestinal tracts are more suitable for telpolide because it has fewer side effects .

 

5. Price and Accessibility Comparison

drug	Price (monthly fee)	Accessibility
Vigovi (Smegglutinin)	$ 1300- $1600	Supply is tight, and some areas are experiencing shortages.
Telpoeptide	$ 1000- $1300	Supply is relatively stable

•       Telpoeptide is relatively cheaper and has a better supply , making it more affordable for users with limited budgets.

•       Due to high demand, supply is tight in some areas, and customers may have to wait in line .

 

6. Which type of weight loss injection is more suitable for you?

1. Choosing Vigovi: 
✔ The target weight loss is 10%-15% , and extreme weight loss is not necessary. 
✔ Habitual overeating, hoping to reduce appetite. 
✔ With a sufficient budget, I can accept a higher price.

2. When choosing telpolide: 
✔ A more significant weight loss ( >20% weight loss) is required. 
✔ If you have previously used Vigavi but it was ineffective, or if the gastrointestinal side effects were too strong. 
✔ I have prediabetes and insulin resistance, and I hope to improve my metabolic health at the same time. 
✔ With a limited budget, I'm looking for a more cost-effective weight loss solution.

 Conclusion: For those seeking significant weight loss, long-term weight maintenance, and minimal side effects, telpolide is a better choice. If gentle weight loss is desired, vigoravir can also meet the needs. The final choice should be based on individual health conditions and budget.